Do you want to read an article? Please log in or register.
Serum levels of hyaluronic acid are associated with COPD severity and predict survival
COPD
Related content
Glucocorticoids and β2-agonists regulate the pathologic metabolism of hyaluronic acid in COPD
Pulm Pharmacol Ther.
Papakonstantinou E, Klagas I, Karakiulakis G, Tamm M, Roth M, Stolz D
doi: 10.1016/j.pupt.2017.08.007.
Asthma
Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab
Respir Med.
Suzukawa M, Matsumoto H, Ohshima N, Tashimo H, Asari I, Tajiri T, Niimi A, Nagase H, Matsui H, Kobayashi N, Shoji S, Ohta K
doi: 10.1016/j.rmed.
IFNΛ3/4 locus polymorphisms and IFNΛ3 circulating levels are associated with COPD severity and outcomes
BMC Pulm Med.
Egli A, Mandal J, Schumann DM, Roth M, Thomas B, Lorne Tyrrell D, Blasi F, Kostikas K, Boersma W, Milenkovic B, Lacoma A, Rentsch K, Rohde GGU, Louis R, Aerts JG, Welte T, Torres A, Tamm M, Stolz D
doi: 10.1186/s12890-018-0616-6.
Asthma
Serum Reactive Oxygen Metabolite Levels Predict Severe Exacerbations of Asthma
PLoS One.
Nakamoto K, Watanabe M, Sada M, Inui T, Nakamura M, Honda K, Wada H, Mikami Y, Matsuzaki H, Horie M, Noguchi S, Yamauchi Y, Koyama H, Kogane T, Kohyama T, Takizawa H
doi: 10.1371/
COPD
Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD
Respir Res.
Leitao Filho FS, Ra SW, Mattman A, Schellenberg RS, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Leung JM, Paul Man SF, Aaron SD, Reed RM, Sin DD; Canadian Respiratory Research Network (CRRN)
doi: 10.1186/s12931-018-0733-z.
ARDS
Serum uric acid, disease severity and outcomes in COVID-19
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Crit Care
Dufour I, Werion A, Belkhir L, Wisniewska A, Perrot M, De Greef J, Schmit G, Yombi JC, Wittebole X, Laterre PF, Jadoul M, Gérard L, Morelle J, CUSL COVID-19 Research Group.
doi: 10.1186/s13054-021-03616-3
RECOMMENDED
ARDS
Serum uric acid, disease severity and outcomes in COVID-19
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Crit Care
Dufour I, Werion A, Belkhir L, Wisniewska A, Perrot M, De Greef J, Schmit G, Yombi JC, Wittebole X, Laterre PF, Jadoul M, Gérard L, Morelle J, CUSL COVID-19 Research Group.
doi: 10.1186/s13054-021-03616-3
COPD
Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
Int J Chron Obstruct Pulmon Dis.
Dilektasli AG, Demirdogen Cetinoglu E, Uzaslan E, Budak F, Coskun F, Ursavas A, Ercan I, Ege E
doi: 10.2147/COPD.S118424.
COPD
Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD
Pulm Pharmacol Ther.
Mandal J, Roth M, Papakonstantinou E, Sun Q, Costa L, Boeck L, Scherr A, Rakic J, Louis R, Milenkovic B, Boersma W, Kostikas K, Blasi F, Aerts J, Rohde G, Lacoma A, Torres A, Welte T, Tamm M, Stolz D
doi: 10.1016/j.pupt.2017.10.011.